
Immunovant, Inc.
USD38.52
+0.01 (+0.03%)
CEO
Eric Venker
IPO Date
2019-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.61
Prev. Close
$38.51
Day Low
$38.24
Day High
$39.13
52W Low
$14.32
52W High
$39.28
Market Cap
$7.91B
Volume
0.61M
| 21 May 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 15 Apr 2026 | Goldman Sachs | Neutral | Neutral | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 9 Feb 2026 | Guggenheim | Buy | Buy | maintain |
| 8 Jan 2026 | Truist Securities | Hold | Hold | maintain |
| 6 Jan 2026 | Wolfe Research | Peer Perform | Outperform | upgrade |
| 15 Dec 2025 | Goldman Sachs | Neutral | Neutral | maintain |